Fernandez-Mercado, M., Pellagatti, A., Di Genua, C., Larrayoz, M., Winkelmann, N., Aranaz, P., . . . Boultwood, J. (2013). Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression.
Cita Chicago (17th ed.)Fernandez-Mercado, M., et al. Mutations in SETBP1 Are Recurrent in Myelodysplastic Syndromes and Often Coexist with Cytogenetic Markers Associated with Disease Progression. 2013.
Cita MLA (9th ed.)Fernandez-Mercado, M., et al. Mutations in SETBP1 Are Recurrent in Myelodysplastic Syndromes and Often Coexist with Cytogenetic Markers Associated with Disease Progression. 2013.
Atenció: Aquestes cites poden no estar 100% correctes.